Adaptive Biotechnologies and Collaborators to Present Data from More Than 25 clonoSEQ® Abstracts at ASH 2019 Demonstrating Clinical Relevance of Standardized, Accurate MRD Testing for Blood Cancer Patients

by NASDAQ Market News December 4, 2019

NASDAQ Market News
Click here to email author

Idorsia and Mochida enter into a license agreement for the supply, co-development and co-marketing of daridorexant in Japan

SI-BONE Names Jeryl (“Jeri”) Hilleman to Board of Directors

Ads